For example, by comparing the level of ApoA-I in patients with nasopharyngeal cancer and ovarian cancer before chemotherapy, a higher level of ApoA-I improved the overall survival after chemotherapy [27]. This evidence concerns the gene APOA1 and ovarian cancer.